Weekly Recap | BAO PHARMA-B +15.36%, surging against a falling marketWeekly Review·Nov 14, 2026 at 05:31 AM02659-1.33%
Weekly Recap | BAO PHARMA-B +9.61%, BJ045 approval and chairman buying drive rallyWeekly Review·Nov 7, 2026 at 06:03 AM02659-1.33%
Bao Pharma surges 12% on BJ045 IND approval and chairman stake buyMarket Movers·Nov 5, 2026 at 03:06 AM02659-1.33%
A USD 90 Million Upfront Anchors Hong Kong Biotech's December RushGlobal Report·Oct 28, 2026 at 03:45 AM02269-3.59%02268-2.08%
Weekly Recap | BAO PHARMA-B -18.85%, hitting a 60-day lowWeekly Review·Oct 24, 2026 at 05:25 AM02659-1.33%
A 95% Discount Buyout Shows Who Really Prices Hong Kong's Small CapsGlobal Report·Oct 20, 2026 at 10:50 AM09929-3.09%06600-2.27%
Hong Kong Biotechs Secure EU Certifications as Shougang’s Green Fuel Project Gains Sinopec BackingGlobal Report·Oct 20, 2026 at 09:17 AM02659-1.33%06132+0.38%
Weekly Recap | BAO PHARMA-B -14.59%, a wild round-trip weekWeekly Review·Oct 17, 2026 at 05:45 AM02659-1.33%